Hospital wastewater as a health monitoring tool
Part of Infections clinical trials.
This trial collects wastewater from the hospital building to monitor for drug-resistant germs. It helps researchers understand how resistance spreads in the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older
- You must be a patient in the SMIT department of Bichat-Claude Bernard hospital during wastewater sampling
- You cannot have objected to the use of your data
- You cannot be under legal protection such as guardianship or curatorship
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks a specific kind of antibiotic-resistant gut bacteria in hospital patients and how it may spread to people living in the same home. It may help researchers understand transmission risk inside households and improve prevention strategies.
This study looks at bacteria (including antibiotic-resistant germs) present when you are admitted to a hospital. It may help doctors understand how often these germs are carried and how to respond early to prevent spread.
This study creates a bank of leftover blood and other samples from patients at two French hospitals. It helps researchers test new, faster ways to diagnose diseases.
This trial looks at antibiotic resistance by testing wastewater in nursing homes. It aims to understand how resistance spreads and how to better protect residents.
This study looks at whether patients in the hospital who carry certain resistant bacteria in their gut are more likely to get infections. The goal is to understand the risk so doctors can better protect you.
This study looks at new ways to fight antibiotic-resistant bacteria in people with certain common infections. It may help by testing approaches tailored to the specific germs found in your urine, lungs, or deeper infections.
Hear when a new Multidrug-resistant Organisms (MDROs) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.